Mesoblast Reports Substantial Operational Progress and Financial Results for the Year Ended June 30, 2020

NEXT STORY
Relay Medical and Fio Corporation Launch Mobile COVID-19 Testing and Tracking Platform
PREV STORY
Genmab Announces Late-Breaking Oral Presentation of Phase 2 innovaTV 204 Study at the ESMO Virtual Congress 2020
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

AB Science receives regulatory authorization to commence a second Phase 2 Covid-19 study

author_avatar
NASDAQ Market News

Apellis Announces FDA Acceptance and Priority Review of the New Drug Application for Pegcetacoplan for the Treatment of PNH

author_avatar
NASDAQ Market News

ADMA Biologics Strengthens its Board of Directors with the Appointment of Young T. Kwon, Ph.D.

author_avatar
NASDAQ Market News